Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer

NCT03871153 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Investigator decided to halt study due to low accrual.

Conditions

Non Small Cell Lung Cancer
Stage III Non-small-cell Lung Cancer

Interventions

DEVICE: Durvalumab
DRUG: Paclitaxel
DRUG: Carboplatin
RADIATION: Radiation
PROCEDURE: Surgical Resection

Sponsor

Greg Durm, MD

Collaborators

[object Object]
[object Object]